(12) United States Patent (10) Patent No.: US 7,919,636 B2 Seeram Et Al
Total Page:16
File Type:pdf, Size:1020Kb
USOO7919636B2 (12) United States Patent (10) Patent No.: US 7,919,636 B2 Seeram et al. (45) Date of Patent: Apr. 5, 2011 (54) PURIFICATIONS OF POMEGRANATE Aviram, M., et al., “Pomegranate juice consumption inhibits serum ELLAGTANNINS AND THEIR USES angiotensin converting enzyme activity and reduces systolic blood THEREOF pressure.” (2001) Atherosclerosis, 158: 195-198. Cerda, B., et al., “Evaluation of bioavailability and metabolism in the (75) Inventors: Navindra P. Seeram, Los Angeles, CA rat of punicalagin, an antioxidant polyphenol from pomegranate juice.” (2003) Eur, J. Nutr., 42:18-28. (US); David Heber, Los Angeles, CA Cerda, B., et al., “Repeated oral administration of high doses of the (US) pomegranate elagitannin punicalaginto rats for 37 days is not toxic.” (2003) J. Agric. Food Chem. 51:3493-3501. (73) Assignee: The Regents of the University of Doig, A., et al., “Isolation and structure elucidation of punicalagin, a California, Oakland, CA (US) toxic hydrolysable tannin, from Terminalia oblongata.” (1990) J. Chem. Soc. Perkin Trans. I, 2317-2321. (*) Notice: Subject to any disclaimer, the term of this El-Toumy, S., et al., “Two ellagitannins from Punica granatum patent is extended or adjusted under 35 heartwood.” (2002) Phytochemistry, 61:971-974. U.S.C. 154(b) by 248 days. Filippich, L., et al., “Hepatotoxic and nephrotoxic principles in Terminalia oblongata.” (1991) Research in Veterinary Science, (21) Appl. No.: 12/143,657 50:17O-177. Gil, M., et al., “Antioxidant activity of pomegranate juice and its (22) Filed: Jun. 20, 2008 relationship with phenolic composition and processing.” (2000) J. Agric. Food Chem., 48:4581-4589. (65) Prior Publication Data Mayer, et al., “Punicalagin and punicalin, two tannins from pome granate peel.” (1977) Liebigs Ann. Chem, 1976-1986. US 2008/0318877 A1 Dec. 25, 2008 Negi, P. et al., “Antioxidant and antimutagenic activities of pome granate peel extracts.” (2003) Food Chemistry, 80:393-397. Related U.S. Application Data Scalbert, A., et al., “Absorption and metabolism of polyphenols in the gut and impact on health.” (2002) Biomed. Pharmacother, 56:276 (63) Continuation of application No. 1 1/395,447, filed on 282. Mar. 30, 2006, now Pat. No. 7,638,640, which is a Tanaka, T., et al., "Tannins and related compounds. XL. Revision of continuation-in-part of application No. the structures of punicalin and punicalagin, and isolation and char PCT/US2005/009337, filed on Mar. 21, 2005. acterization of 2-O-Galloylpunacalin from the bark of Punica granatum L.” (1986) Chem. Pharm. Bull., 34(2):650-655. (60) Provisional application No. 60/556,322, filed on Mar. Tanaka, T., et al., “Tannins and related compounds. XLL. Isolation 24, 2004. and characterization of novel ellagitannins, punicacorteins A, B, C and D, and punigluconin from the bark of Punica granatum L.” (51) Int. Cl. (1986) Chem. Pharm. Bull., 34(2): 656-663. CO7D 49.3/00 (2006.01) Vidal, A., et al., “Studies on the toxicity of Punica granatum L. AOIK 43/04 (2006.01) (Punicaceae) whole fruit extracts.” (2003) Journal of Ethnopharmacology, 89:295-300. AOIN 43/42 (2006.01) Tanaka; et al., “Punicafolin, an Ellagitannin from the Leaves of AOIN 43/16 (2006.01) Punica Granatum”, Phytochemistry (1985), 24(9): 2075-2078. (52) U.S. Cl. ........ 549/278: 514/292; 514/453: 514/456: 514/27 * cited by examiner (58) Field of Classification Search .................. 549/278; 514/27, 292, 453, 456 Primary Examiner — Nizal S Chandrakumar See application file for complete search history. (74) Attorney, Agent, or Firm — Bozicevic, Field & Francis LLP: Pamela J. Sherwood (56) References Cited (57) ABSTRACT OTHER PUBLICATIONS Compositions of purified and biologically active ellagitan Gil et al. Journal of Agricultural and Food Chemistry, 2000, 48. nins are provided by separation from pomegranate husk using 4581-4589. a method of extraction and purification using a solid poly Mayer et al. (Liebigs Annalender Chemie 1977, 1976-1986).* meric adsorbent and the uses of the said compounds. Tanaka; et al., “Punicafolin, an Ellagitannin from the Leaves of Punica granatum”, Phytochemistry (1985), 24(9):2075-2078. 10 Claims, 4 Drawing Sheets U.S. Patent Apr. 5, 2011 Sheet 1 of 4 US 7,919,636 B2 4a 4 5.0 1 O,O 15.0 0.00 25.0 30.0 350 400 45 Minute 0.1- - Fig. 1B AU 1. O. f t i 5.O O.O 15.0 200 25.O 30.0 35.0 400 45 Minute 5.0 O.O 15.O 20.0 25.0 3O.O 35.0 40.0 45 U.S. Patent Apr. 5, 2011 Sheet 2 of 4 US 7,919,636 B2 Z3Inôl U.S. Patent Apr. 5, 2011 Sheet 4 of 4 US 7,919,636 B2 punicalagin MSMS #74 RTO73 AV: ; NL. 64 E4. T-p Fulirns 2 1083.0G29.00295.00-200.00 782 100 95 90 5 O 602 1083.0 79.2 0- 549. 575.2 763.4 - 3188 393.2 453 7006 1064.5 465.0 6062 . ... - - - 683.2 86.9 930.9 988.9 O-TT3374 filmilLl The| Thifthl lithi| Th Title| hill ill, TTTTTTTTTTTTTTTTTTTTTTT8506 894.9 l fill THTTTTTTTTTTTTT 300 400 500 600 700 800 900 OOO 100 200 miz Figure 3B US 7,919,636 B2 1. 2 PURIFICATIONS OF POMEGRANATE compounds, and extracts comprising total pomegranate tan ELLAGTANNINS AND THEIR USES nins, are useful for a variety of applications, including phar THEREOF maceutical, neutraceutical, cosmetic, and food uses. In one embodiment of the invention, dried pomegranate GOVERNMENT RIGHTS peels are ground and Suspended with an alcohol Such as methanol. A rapid polymeric adsorbent column is used to This invention was made with Government support of purify pomegranate tannins from an aqueous or alcoholic Grant No. PSOAT00151 awarded by the National Institutes of extract, which extract is derived from a source of elagitan Health. The Government has certain rights in this invention. nins such as a variety of plant extracts, including Punica Recent research has shown that pomegranate (Punica 10 granatum L.) juice and pomegranate extracts exhibit potent granatum L., and the like. The tannins are adsorbed to the biological properties attributable to the presence of polyphe columns, and followed by cleansing, gravity evacuation, and nols known as elagitannins. These hydrolysable tannins are vacuum aspiration of fluid from the column, the adsorbed present in high levels in pomegranates and include punicala tannins are eluted from the adsorbent solid and the solvent gin anomers commonly referred to as punicalagins punicalin 15 removed in vacuo to yield a powder of highly concentrated gallagic acid and elagic acid Pomegranate elagitannins have total tannins comprising a high percentage (e.g., 80%) of been identified as the active antioxidant compounds respon punicalagin anomers, as well as a significant percentage of sible for protecting low-density lipoprotein cholesterol from ellagic acid. Additional chromatography steps may be per oxidation in Vivo, a key step in the pathogenesis of athero formed to provide for highly purified compositions of gal Sclerosis. The punicalagins are key compounds responsible lagic acid or punicalagin. for the antioxidant properties of pomegranate extracts. How The present invention also provides a method for produc ever, research has shown that the synergistic combination of ing a mixture comprising ellagitannins from pomegranate. punicalagins with other minor pomegranate elagitannins, The method may include the use of enzymes Such as extrac specifically punicalin and gallagic acid, results in Superior tase and pectinase. The method may include the steps of biological activities. Unfortunately, there are no methods cur 25 providing an aqueous solution containing the ellagitannins rently available for rapid and large scale production of these from the pomegranate; removing the elagitannins onto a minor pomegranate elagitannins. This invention proposes a resin Surface from the aqueous solution; eluting the resin method to produce ellagitannins from pomegranates and out Surface with a eluant to remove the ellagitannins from the lines their uses. resin Surface; and separating the eluant from the elagitan Current studies on elagitannins include antioxidant prop 30 nins. The starting material may be fresh, or quick frozen and erties, anticancer potential, the inhibition of COX-1 and thawed. The material is then disrupted, and the elagitannins COX-2 enzymes; anti-athersclerotic activity; inhibition of the nuclear transcription factor NF-kB, repression of glutathione extracted from the pulp into an aqueous solution. expression, and anti-adhesion effects; and the like. The extracts thus obtained may be used in the preparation Punicalagin is the predominant pomegranate elagitannin 35 of tinctures, cosmetics and other therapeutic formulae, as (present in levels 2 g/L in commercial pomegranate juice), food biopreservatives, in the nutraceutical industry; and the and is responsible for the high antioxidant activity of pome like. The compositions also find use as a source of ellagic acid granate juice. However, little is known about the biological derivatives, including hydrolysable elagitannins, for use in in properties, bioavailability and metabolism of other pome vitro and in vivo biological studies. The compounds thus granate elagitannins such as gallagic acid. 40 isolated are reported to have antioxidant and anti-inflamma Previous methods of isolating pomegranate elagitannins tory activity. include time consuming preparative high-performance liquid chromatographic (HPLC) and/or column chromatographic) BRIEF DESCRIPTION OF THE DRAWINGS methods. In view of the commercial interest in these com pounds, the development of inexpensive, high throughput 45 FIG. 1A: HPLC chromatogram of total pomegranate tan methods of purifications of particular interest. nins (TPT) purified from fruit husk. Peaks were identified by comparison of their retention times with pure standards as SUMMARY OF THE INVENTION punicalagin anomers (1) and elagic acid (4), corresponding to m/z. 1083 and m/z. 301 in LCMS, respectively. Peak 4a was Compositions of purified and biologically active elagitan 50 identified as elagic acid hexoside based on its ion at m/z.